Bio-Thera Kicks Off Ustekinumab Trial

Phase I Study Follows Similar Efforts From Rival Stelara Biosimilars

Clinical_Trial_Puzzle
Bio-Thera is starting clinical trials for its ustekinumab Stelara biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products